Jasper Therapeutics Inc (JSPR) — Long-term Investment Intensity

Latest as of June 2021: 383.8%

Jasper Therapeutics Inc (JSPR) has a Long-term Investment Intensity of 383.8% as of June 2021. Long-term investments of $100.13 Million represent 383.8% of total assets of $26.09 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check cash flow quality index of Jasper Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.

LT Investment Intensity

383.8%
LT Investments / Total Assets

Long-term Investments

$100.13 Million
USD

Total Assets

$26.09 Million
USD

Country

USA
NASDAQ

Jasper Therapeutics Inc Long-term Investment Intensity (2019–2020)

This chart shows how Jasper Therapeutics Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2019 to 2020. As of June 2021, the intensity stands at 383.8%, reflecting long-term investments of $100.13 Million against total assets of $26.09 Million USD. Explore debt repayment capacity of Jasper Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Jasper Therapeutics Inc (2019–2020)

The table below presents the year-by-year Long-term Investment Intensity for Jasper Therapeutics Inc from 2019 to 2020, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Jasper Therapeutics Inc.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2020 429.6% $100.34 Million $23.36 Million ▲ +61.5 pp
2019 368.1% $100.15 Million $27.21 Million
pp = percentage points